NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 22, 2025 — Learn how the American Heart Association's Get With The Guidelines program is transforming heart failure care, leading to improved patient outcomes and reduced mortality rates. Discover the impact of evidence-based practices and data-driven benchmarking in enhancing the quality of care for heart failure patients.
May 22, 2025 — Tonix Pharmaceuticals CEO, Seth Lederman, discusses company updates and product pipeline at A.G.P.'s Annual Healthcare Company Showcase. Learn more about Tonix's innovative approach to pain management therapies and public health solutions.
May 22, 2025 — NanoViricides President Dr. Anil Diwan praises FDA's COVID-19 booster shot policy, emphasizes need for alternatives like antiviral NV-387. Learn more about NanoViricides' nanomaterials for antiviral therapy.
May 22, 2025 — Creative Biolabs announces enhancements to their Extracellular Vesicle platform, focusing on exosome isolation, characterization, and RNA sequencing. The upgrades cater to the demand in cancer, neurodegenerative, and autoimmune disease research, offering accurate data for early disease diagnostics and potential therapeutic developments.
May 22, 2025 — Purpose Healing Center in Scottsdale, Arizona, is now accepting AHCCCS plans for addiction and mental health treatment. This expansion of access to care demonstrates the center's commitment to providing high-quality treatment to more residents in need.
May 22, 2025 — Discover the revolutionary anti-aging formula, Prime Spermidine, by Bone Science. Harnessing the power of plant-based spermidine, this product offers high purity and superior bioavailability for optimal cellular renewal and vitality.
May 21, 2025 — Dr. Barry Quart joins Connect Biopharma to advance rademikibart, a novel treatment for asthma and COPD, showcasing rapid action and safety in clinical trials.
May 21, 2025 — Telomir Pharmaceuticals receives $3 million investment from The Bayshore Trust, advancing key drug candidates Telomir-1 and Telomir-Ag2. CEO Erez Aminov emphasizes shareholder-friendly financing. IND submission for Telomir-1 planned by year-end. Visit the press release for more details.
May 21, 2025 — Tonix Pharmaceuticals announces the initiation of the Phase 2 OASIS trial to evaluate TNX-102 SL for reducing acute stress reaction severity. CEO Dr. Seth Lederman emphasizes the urgent need for treatments following traumatic events in civilian and military populations.
May 21, 2025 — Adageis introduces AI-powered platform for healthcare providers to transition to value-based care models. Learn how this innovative solution simplifies insurance contracts and data reporting for better outcomes and financial performance.
May 21, 2025 — GeoVax Labs collaborates with US government and private sector to revolutionize pharmaceutical manufacturing with AI integration. Learn how this initiative enhances national health security and supply chain resilience.
May 21, 2025 — SeaStar Medical Holding Corp. CEO, Eric Schlorff, discusses breakthrough therapies for critically ill patients with Benzinga. Learn about QUELIMMUNE, their FDA-approved treatment for pediatric patients with acute kidney injury, and their ongoing trials for a second therapeutic device with broad applications.
May 21, 2025 — Lionheart Health, a California-based biotech company, named semi-finalist in $101M XPRIZE Healthspan Competition. Discover their bioelectric technology platform and potential impact on longevity and healthy aging.
May 21, 2025 — New research reveals how the PREVENT risk calculator accurately identifies heart attack risk and calcium buildup in heart arteries, emphasizing the importance of tailored care and preventative treatments. Learn more about the study findings and implications for cardiovascular health.
May 21, 2025 — Discover how Creative Biolabs is revolutionizing probiotic research with their Lactobacillus development solutions. Explore strain screening, functional validation, and gene editing capabilities for engineered probiotics.
May 20, 2025 — Lindsay Ashley, CFO of Centre for Neuro Skills, appointed chair of 2025 Kern County Heart and Stroke Walk by American Heart Association. Event raises funds for heart disease awareness and promotes community health. Impacting lives affected by cardiovascular issues with resources for mental and physical well-being.
May 20, 2025 — Learn about the connection between Epstein-Barr virus and Multiple Sclerosis and its implications for biopharmaceutical research. Discover how Clene Inc. (NASDAQ: CLNN) is leveraging this knowledge to drive innovation in MS treatment.
May 20, 2025 — Medical technology company Intelligent Bio Solutions expands its international footprint by launching localized websites in Arabic, Italian, and Spanish to cater to over 1.4 billion people across Latin America, the Middle East, and Southern Europe. The move aligns with the increased demand for workplace safety and compliance solutions.
May 20, 2025 — Quantum BioPharma signs agreement with contract research organization to prepare Lucid-21-302 IND application targeting multiple sclerosis. The patented neuroprotective therapy aims to prevent demyelination, offering potential benefits for patients with MS and other neurodegenerative disorders.
May 20, 2025 — Valluxy introduces a new collection of luxury in-home saunas in Dubai, featuring infrared, traditional, and hybrid models. These saunas provide health benefits like detoxification and pain relief. Invest in your well-being with Valluxy's premium saunas for a spa-like experience at home.